Trial Profile
Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results Trial in Japan
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 May 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Acute coronary syndromes; Type 2 diabetes mellitus
- Focus Adverse reactions; Pharmacodynamics
- Acronyms LEADER-J; READ
- 05 Dec 2015 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 01 Jun 2015 Status changed from recruiting to active, no longer recruiting as per University Hospital Medical Information Network - Japan record.
- 02 Jun 2014 Planned End Date changed from 31 Jul 2014 to 31 Jul 2015 as reported by University Hospital Medical Information Network - Japan.